#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Juvenile psoriatic arthritis Small cell lung cancer Blood iron increased Alveolar rhabdomyosarcoma Pancreatic carcinoma Piriformis syndrome Congenital cystic kidney disease Osteosarcoma metastatic Neurodermatitis Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Eosinophilic oesophagitis X-linked lymphoproliferative syndrome Immune-mediated enterocolitis Anal fistula Undifferentiated sarcoma More trials…

    Learn about Rare Diseases

    Glomerulonephritis membranous Congenital generalised lipodystrophy – Treatment Pemphigoid Alagille syndrome – Diagnostics KBG syndrome – Diagnostics IgA nephropathy – Diagnostics Loeys-Dietz syndrome – Basic Information X-linked lymphoproliferative syndrome – Treatment Bronchopulmonary dysplasia – Basic Information Encephalitis autoimmune – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Clozapine AGALSIDASE BETA Cyclophosphamide Monohydrate Dostarlimab Temocillin Sodium Autologous Chondrocytes GSKVX000000034795 Monalizumab Tumor Necrosis Factor-Alpha 19Cp02 Medroxyprogesterone Acetate S227928 GOCATAMIG Tipiracil Norucholic Acid Elebsiran Treprostinil Sodium Givinostat L-Arginine Hydrochloride Sasanlimab More therapies…

    Learn about Your Condition

    Mitochondrial DNA depletion Perthes disease Obstructive pancreatitis Open angle glaucoma Cardiovascular disorder Glucose tolerance impaired Fallopian tube cancer Myopia Ectopic pregnancy Krabbe's disease Epithelioid sarcoma Normal pressure hydrocephalus Hypoaesthesia Hyperplasia adrenal Rectal cancer stage III More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Dry eye

  • Study on the Effectiveness of PRGF Eye Drops for Treating Dry Eye in Glaucoma Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Glaucoma
    • Dry eye
    Investigated Drugs:
    • Platelet Concentrate
    Spain

  • Evaluation of Mesenchymal Stem Cell Eye Injections for Dry Eye Disease in Patients with Graft-versus-Host Disease Who Haven’t Responded to Standard Treatments

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Dry eye
    Investigated Drugs:
    • Allogeneic Adipose-Derived Adult Mesenchymal Stem Cells Expanded
    Spain

  • Study on the Use of PRGF Eye Drops for Treating Dry Eye Disease in Patients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Dry eye
    Investigated Drugs:
    • Platelet Concentrate
    • Hypromellose
    • Sodium Chloride
    Spain

  • Study on the Use of PRGF and Hypromellose Eye Drops for Treating Dry Eye Disease in Patients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Dry eye
    Investigated Drugs:
    • Platelet Concentrate
    • Hypromellose
    • Sodium Chloride
    Spain

  • Study on the Effects of Ianalumab in Adults with Rheumatoid Arthritis, Systemic Lupus Erythematosus, or Sjögren’s Disease

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Dry eye
    • Rheumatoid arthritis
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Entecavir
    • Ianalumab
    • Tenofovir Disoproxil
    Czechia Germany Hungary Italy The Netherlands Poland +1

  • Study on the Safety and Effectiveness of Cenegermin Eye Drops for Patients with Dry Eye Disease

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Dry eye
    Investigated Drugs:
    • Calcium Chloride
    • Fluorescein Sodium
    • Potassium Chloride
    Italy
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!